 | • レポートコード：B-GIR08C5676 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、乳癌用標的薬の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、病院、画像診断センター、癌研究所、その他等に区分しました。乳癌用標的薬の世界市場概観、企業動向、企業別乳癌用標的薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・乳癌用標的薬の市場概観 ・乳癌用標的薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・乳癌用標的薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・乳癌用標的薬の世界市場規模 ・乳癌用標的薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・乳癌用標的薬のアメリカ市場規模推移 ・乳癌用標的薬のカナダ市場規模推移 ・乳癌用標的薬のメキシコ市場規模推移 ・乳癌用標的薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・乳癌用標的薬のドイツ市場規模推移 ・乳癌用標的薬のイギリス市場規模推移 ・乳癌用標的薬のロシア市場規模推移 ・乳癌用標的薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・乳癌用標的薬の日本市場規模推移 ・乳癌用標的薬の中国市場規模推移 ・乳癌用標的薬の韓国市場規模推移 ・乳癌用標的薬のインド市場規模推移 ・乳癌用標的薬の東南アジア市場規模推移 ・乳癌用標的薬の南米市場分析（ブラジル、アルゼンチン等） ・乳癌用標的薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・乳癌用標的薬の種類別分析/販売量、売上、市場シェア（） ・乳癌用標的薬の用途別分析/市場規模（病院、画像診断センター、癌研究所、その他） ・乳癌用標的薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・乳癌用標的薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Targeted Drugs for Breast Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Targeted Drugs for Breast Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Targeted Drugs for Breast Cancer market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Pfizer
Eli Lilly
Novartis
CANbridge
Puma Biotechnology
AstraZeneca
Chugai Pharmaceutical
Eisai
GlaxoSmithKline
Bristol-Myers Squibb
Otsuka Pharmaceutical
Merck
BioMarin
Hengrui Pharmaceutical
Beijing Biostar Technologies
Bayer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
HER-2 Targeted Drugs
CDK4/6 Inhibitors
PARP Targeted Drugs
PI3K/AKT/mTor Pathway Inhibitors
ER Targeted Drugs
Aromatase Inhibitors
Tubulin Inhibitors
VEGF Targeted Drugs
YTMS Targeted Drugs
Other
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
Table of Contents
1 Targeted Drugs for Breast Cancer Market Overview
1.1 Product Overview and Scope of Targeted Drugs for Breast Cancer
1.2 Classification of Targeted Drugs for Breast Cancer by Types
1.2.1 Global Targeted Drugs for Breast Cancer Revenue Comparison by Types (2019-2024)
1.2.2 Global Targeted Drugs for Breast Cancer Revenue Market Share by Types in 2018
1.2.3 HER-2 Targeted Drugs
1.2.4 CDK4/6 Inhibitors
1.2.5 PARP Targeted Drugs
1.2.6 PI3K/AKT/mTor Pathway Inhibitors
1.2.7 ER Targeted Drugs
1.2.8 Aromatase Inhibitors
1.2.9 Tubulin Inhibitors
1.2.10 VEGF Targeted Drugs
1.2.11 YTMS Targeted Drugs
1.2.12 Other
1.3 Global Targeted Drugs for Breast Cancer Market by Application
1.3.1 Global Targeted Drugs for Breast Cancer Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Targeted Drugs for Breast Cancer Market by Regions
1.4.1 Global Targeted Drugs for Breast Cancer Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Targeted Drugs for Breast Cancer Status and Prospect (2014-2024)
1.5 Global Market Size of Targeted Drugs for Breast Cancer (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Targeted Drugs for Breast Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.2 Teva
2.2.1 Business Overview
2.2.2 Targeted Drugs for Breast Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Targeted Drugs for Breast Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.4 Hikma
2.4.1 Business Overview
2.4.2 Targeted Drugs for Breast Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hikma Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.5 Hengrui Medicine
2.5.1 Business Overview
2.5.2 Targeted Drugs for Breast Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hengrui Medicine Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.6 Cipla
2.6.1 Business Overview
2.6.2 Targeted Drugs for Breast Cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cipla Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.7 Reliance Group
2.7.1 Business Overview
2.7.2 Targeted Drugs for Breast Cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Reliance Group Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.8 Hetero
2.8.1 Business Overview
2.8.2 Targeted Drugs for Breast Cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hetero Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Targeted Drugs for Breast Cancer Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.10 Eli Lilly
2.10.1 Business Overview
2.10.2 Targeted Drugs for Breast Cancer Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eli Lilly Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.11 Novartis
2.11.1 Business Overview
2.11.2 Targeted Drugs for Breast Cancer Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novartis Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.12 CANbridge
2.12.1 Business Overview
2.12.2 Targeted Drugs for Breast Cancer Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 CANbridge Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.13 Puma Biotechnology
2.13.1 Business Overview
2.13.2 Targeted Drugs for Breast Cancer Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Puma Biotechnology Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.14 AstraZeneca
2.14.1 Business Overview
2.14.2 Targeted Drugs for Breast Cancer Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 AstraZeneca Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.15 Chugai Pharmaceutical
2.15.1 Business Overview
2.15.2 Targeted Drugs for Breast Cancer Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Chugai Pharmaceutical Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.16 Eisai
2.16.1 Business Overview
2.16.2 Targeted Drugs for Breast Cancer Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Eisai Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.17 GlaxoSmithKline
2.17.1 Business Overview
2.17.2 Targeted Drugs for Breast Cancer Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 GlaxoSmithKline Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.18 Bristol-Myers Squibb
2.18.1 Business Overview
2.18.2 Targeted Drugs for Breast Cancer Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Bristol-Myers Squibb Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.19 Otsuka Pharmaceutical
2.19.1 Business Overview
2.19.2 Targeted Drugs for Breast Cancer Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Otsuka Pharmaceutical Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.20 Merck
2.20.1 Business Overview
2.20.2 Targeted Drugs for Breast Cancer Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Merck Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.21 BioMarin
2.21.1 Business Overview
2.2.2 Targeted Drugs for Breast Cancer Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 BioMarin Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.22 Hengrui Pharmaceutical
2.22.1 Business Overview
2.22.2 Targeted Drugs for Breast Cancer Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Hengrui Pharmaceutical Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.23 Beijing Biostar Technologies
2.23.1 Business Overview
2.23.2 Targeted Drugs for Breast Cancer Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Beijing Biostar Technologies Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.24 Bayer
2.24.1 Business Overview
2.24.2 Targeted Drugs for Breast Cancer Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Bayer Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
3 Global Targeted Drugs for Breast Cancer Market Competition, by Players
3.1 Global Targeted Drugs for Breast Cancer Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Targeted Drugs for Breast Cancer Players Market Share
3.2.2 Top 10 Targeted Drugs for Breast Cancer Players Market Share
3.3 Market Competition Trend
4 Global Targeted Drugs for Breast Cancer Market Size by Regions
4.1 Global Targeted Drugs for Breast Cancer Revenue and Market Share by Regions
4.2 North America Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.3 Europe Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.5 South America Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5 North America Targeted Drugs for Breast Cancer Revenue by Countries
5.1 North America Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
5.2 USA Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5.3 Canada Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5.4 Mexico Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6 Europe Targeted Drugs for Breast Cancer Revenue by Countries
6.1 Europe Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
6.2 Germany Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.3 UK Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.4 France Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.5 Russia Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.6 Italy Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Targeted Drugs for Breast Cancer Revenue by Countries
7.1 Asia-Pacific Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
7.2 China Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.3 Japan Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.4 Korea Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.5 India Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8 South America Targeted Drugs for Breast Cancer Revenue by Countries
8.1 South America Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
8.2 Brazil Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8.3 Argentina Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8.4 Colombia Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Targeted Drugs for Breast Cancer by Countries
9.1 Middle East and Africa Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
9.2 Saudi Arabia Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.3 UAE Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.4 Egypt Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.5 Nigeria Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.6 South Africa Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
10 Global Targeted Drugs for Breast Cancer Market Segment by Type
10.1 Global Targeted Drugs for Breast Cancer Revenue and Market Share by Type (2014-2019)
10.2 Global Targeted Drugs for Breast Cancer Market Forecast by Type (2019-2024)
10.3 HER-2 Targeted Drugs Revenue Growth Rate (2014-2024)
10.4 CDK4/6 Inhibitors Revenue Growth Rate (2014-2024)
10.5 PARP Targeted Drugs Revenue Growth Rate (2014-2024)
10.6 PI3K/AKT/mTor Pathway Inhibitors Revenue Growth Rate (2014-2024)
10.7 ER Targeted Drugs Revenue Growth Rate (2014-2024)
10.8 Aromatase Inhibitors Revenue Growth Rate (2014-2024)
10.9 Tubulin Inhibitors Revenue Growth Rate (2014-2024)
10.10 VEGF Targeted Drugs Revenue Growth Rate (2014-2024)
10.11 YTMS Targeted Drugs Revenue Growth Rate (2014-2024)
10.12 Other Revenue Growth Rate (2014-2024)
11 Global Targeted Drugs for Breast Cancer Market Segment by Application
11.1 Global Targeted Drugs for Breast Cancer Revenue Market Share by Application (2014-2019)
11.2 Targeted Drugs for Breast Cancer Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Drug Center Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Targeted Drugs for Breast Cancer Market Size Forecast (2019-2024)
12.1 Global Targeted Drugs for Breast Cancer Market Size Forecast (2019-2024)
12.2 Global Targeted Drugs for Breast Cancer Market Forecast by Regions (2019-2024)
12.3 North America Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.4 Europe Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.6 South America Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Targeted Drugs for Breast Cancer Picture
Table Product Specifications of Targeted Drugs for Breast Cancer
Table Global Targeted Drugs for Breast Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Targeted Drugs for Breast Cancer Revenue Market Share by Types in 2018
Figure HER-2 Targeted Drugs Picture
Figure CDK4/6 Inhibitors Picture
Figure PARP Targeted Drugs Picture
Figure PI3K/AKT/mTor Pathway Inhibitors Picture
Figure ER Targeted Drugs Picture
Figure Aromatase Inhibitors Picture
Figure Tubulin Inhibitors Picture
Figure VEGF Targeted Drugs Picture
Figure YTMS Targeted Drugs Picture
Figure Other Picture
Table Global Targeted Drugs for Breast Cancer Revenue (Million USD) by Application (2014-2024)
Figure Targeted Drugs for Breast Cancer Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global Market Targeted Drugs for Breast Cancer Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Targeted Drugs for Breast Cancer Type and Applications
Table Roche Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Targeted Drugs for Breast Cancer Type and Applications
Table Teva Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Targeted Drugs for Breast Cancer Type and Applications
Table Mylan Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Basic Information, Manufacturing Base and Competitors
Table Hikma Targeted Drugs for Breast Cancer Type and Applications
Table Hikma Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table Hengrui Medicine Targeted Drugs for Breast Cancer Type and Applications
Table Hengrui Medicine Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Targeted Drugs for Breast Cancer Type and Applications
Table Cipla Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Reliance Group Basic Information, Manufacturing Base and Competitors
Table Reliance Group Targeted Drugs for Breast Cancer Type and Applications
Table Reliance Group Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Basic Information, Manufacturing Base and Competitors
Table Hetero Targeted Drugs for Breast Cancer Type and Applications
Table Hetero Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Targeted Drugs for Breast Cancer Type and Applications
Table Pfizer Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Targeted Drugs for Breast Cancer Type and Applications
Table Eli Lilly Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Targeted Drugs for Breast Cancer Type and Applications
Table Novartis Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table CANbridge Basic Information, Manufacturing Base and Competitors
Table CANbridge Targeted Drugs for Breast Cancer Type and Applications
Table CANbridge Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Puma Biotechnology Basic Information, Manufacturing Base and Competitors
Table Puma Biotechnology Targeted Drugs for Breast Cancer Type and Applications
Table Puma Biotechnology Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Targeted Drugs for Breast Cancer Type and Applications
Table AstraZeneca Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Chugai Pharmaceutical Targeted Drugs for Breast Cancer Type and Applications
Table Chugai Pharmaceutical Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Targeted Drugs for Breast Cancer Type and Applications
Table Eisai Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Targeted Drugs for Breast Cancer Type and Applications
Table GlaxoSmithKline Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Targeted Drugs for Breast Cancer Type and Applications
Table Bristol-Myers Squibb Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Otsuka Pharmaceutical Targeted Drugs for Breast Cancer Type and Applications
Table Otsuka Pharmaceutical Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Targeted Drugs for Breast Cancer Type and Applications
Table Merck Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table BioMarin Basic Information, Manufacturing Base and Competitors
Table BioMarin Targeted Drugs for Breast Cancer Type and Applications
Table BioMarin Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Hengrui Pharmaceutical Targeted Drugs for Breast Cancer Type and Applications
Table Hengrui Pharmaceutical Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Beijing Biostar Technologies Basic Information, Manufacturing Base and Competitors
Table Beijing Biostar Technologies Targeted Drugs for Breast Cancer Type and Applications
Table Beijing Biostar Technologies Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Targeted Drugs for Breast Cancer Type and Applications
Table Bayer Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Global Targeted Drugs for Breast Cancer Revenue (Million USD) by Players (2014-2019)
Table Global Targeted Drugs for Breast Cancer Revenue Share by Players (2014-2019)
Figure Global Targeted Drugs for Breast Cancer Revenue Share by Players in 2017
Figure Global Targeted Drugs for Breast Cancer Revenue Share by Players in 2018
Figure Global Top 5 Players Targeted Drugs for Breast Cancer Revenue Market Share in 2018
Figure Global Top 10 Players Targeted Drugs for Breast Cancer Revenue Market Share in 2018
Figure Global Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Targeted Drugs for Breast Cancer Revenue (Million USD) by Regions (2014-2019)
Table Global Targeted Drugs for Breast Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Targeted Drugs for Breast Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Targeted Drugs for Breast Cancer Revenue Market Share by Regions in 2018
Figure North America Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Europe Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure South America Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table North America Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
Table North America Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure USA Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Canada Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Mexico Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Europe Targeted Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Europe Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Europe Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Germany Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure UK Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure France Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Russia Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Italy Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Targeted Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure China Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Japan Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Korea Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure India Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table South America Targeted Drugs for Breast Cancer Revenue by Countries (2014-2019)
Table South America Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Brazil Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Argentina Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Colombia Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Targeted Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Targeted Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Targeted Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Saudi Arabia Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure UAE Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Egypt Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Nigeria Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure South Africa Targeted Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Global Targeted Drugs for Breast Cancer Revenue (Million USD) by Type (2014-2019)
Table Global Targeted Drugs for Breast Cancer Revenue Share by Type (2014-2019)
Figure Global Targeted Drugs for Breast Cancer Revenue Share by Type (2014-2019)
Figure Global Targeted Drugs for Breast Cancer Revenue Share by Type in 2018
Table Global Targeted Drugs for Breast Cancer Revenue Forecast by Type (2019-2024)
Figure Global Targeted Drugs for Breast Cancer Market Share Forecast by Type (2019-2024)
Figure Global HER-2 Targeted Drugs Revenue Growth Rate (2014-2019)
Figure Global CDK4/6 Inhibitors Revenue Growth Rate (2014-2019)
Figure Global PARP Targeted Drugs Revenue Growth Rate (2014-2019)
Figure Global PI3K/AKT/mTor Pathway Inhibitors Revenue Growth Rate (2014-2019)
Figure Global ER Targeted Drugs Revenue Growth Rate (2014-2019)
Figure Global Aromatase Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Tubulin Inhibitors Revenue Growth Rate (2014-2019)
Figure Global VEGF Targeted Drugs Revenue Growth Rate (2014-2019)
Figure Global YTMS Targeted Drugs Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Targeted Drugs for Breast Cancer Revenue by Application (2014-2019)
Table Global Targeted Drugs for Breast Cancer Revenue Share by Application (2014-2019)
Figure Global Targeted Drugs for Breast Cancer Revenue Share by Application (2014-2019)
Figure Global Targeted Drugs for Breast Cancer Revenue Share by Application in 2018
Table Global Targeted Drugs for Breast Cancer Revenue Forecast by Application (2019-2024)
Figure Global Targeted Drugs for Breast Cancer Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Drug Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Targeted Drugs for Breast Cancer Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Targeted Drugs for Breast Cancer Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Targeted Drugs for Breast Cancer Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Europe Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure South America Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Targeted Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
乳癌用HER-2標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global HER-2 Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…- 乳癌VEGF標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global VEGF Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…
- 乳癌用ER標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global ER Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 乳がんPI3K / AKT / mTor経路阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global PI3K/AKT/mTor Pathway Inhibitors for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following ye…
- 乳癌用内分泌療法薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Endocrine Therapy Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espe…